Small-molecule anticancer compounds selectively target the hemopexin domain of matrix metalloproteinase-9
about
Unraveling the role of KIAA1199, a novel endoplasmic reticulum protein, in cancer cell migrationGelatinase B/MMP-9 in Tumour Pathogenesis and ProgressionNeutrophil-Derived Proteases in the Microenvironment of Pancreatic Cancer -Active Players in Tumor ProgressionA systems biology view of blood vessel growth and remodellingBiochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decadeTumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer.Cutting Edge: MMP-9 inhibits IL-23p19 expression in dendritic cells by targeting membrane stem cell factor affecting lung IL-17 response.A novel CD44-binding peptide from the pro-matrix metalloproteinase-9 hemopexin domain impairs adhesion and migration of chronic lymphocytic leukemia (CLL) cells.Novel MT1-MMP small-molecule inhibitors based on insights into hemopexin domain function in tumor growthMatrix metalloproteinase-19 promotes metastatic behavior in vitro and is associated with increased mortality in non-small cell lung cancer.BMP4 inhibits the proliferation of breast cancer cells and induces an MMP-dependent migratory phenotype in MDA-MB-231 cells in 3D environmentIdentification of matrix metalloproteinase inhibitors by chemical arrays.Recruitment of Matrix Metalloproteinase-9 (MMP-9) to the Fibroblast Cell Surface by Lysyl Hydroxylase 3 (LH3) Triggers Transforming Growth Factor-β (TGF-β) Activation and Fibroblast DifferentiationTargeting Matrix Metalloproteinases in Cancer: Bringing New Life to Old IdeasMatrix metalloproteinases as breast cancer drivers and therapeutic targets.A 17-residue sequence from the matrix metalloproteinase-9 (MMP-9) hemopexin domain binds α4β1 integrin and inhibits MMP-9-induced functions in chronic lymphocytic leukemia B cells.ATP6V1H Deficiency Impairs Bone Development through Activation of MMP9 and MMP13Elevated Expression of Matrix Metalloproteinase-9 not Matrix Metalloproteinase-2 Contributes to Progression of Extracranial Arteriovenous Malformation.Multiple myeloma-derived MMP-13 mediates osteoclast fusogenesis and osteolytic diseaseExtracellular matrix determinants and the regulation of cancer cell invasion stratagems.Drug-induced hepatotoxicity in cancer patients - implication for treatment.Epithelial derived-matrix metalloproteinase (MMP9) exhibits a novel defensive role of tumor suppressor in colitis associated cancer by activating MMP9-Notch1-ARF-p53 axisSTAT3 is involved in esophageal carcinogenesis through regulation of Oct-1.Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer.Matrix metalloproteinase MMP9 maintains epithelial barrier function and preserves mucosal lining in colitis associated cancer.Targeting the Hemopexin-like Domain of Latent Matrix Metalloproteinase-9 (proMMP-9) with a Small Molecule Inhibitor Prevents the Formation of Focal Adhesion Junctions.Bifunctional Inhibitors as a New Tool To Reduce Cancer Cell Invasion by Impairing MMP-9 Homodimerization.SMAR1 inhibits Wnt/β-catenin signaling and prevents colorectal cancer progression.Kinetic characterization of 4,4′-biphenylsulfonamides as selective non-zinc binding MMP inhibitorsMatrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances
P2860
Q24321056-C3217094-B104-41F7-9B54-7F2B29BFDA6BQ24568374-3988DDB3-3293-4BC2-B7FB-15A46BE73236Q26765238-F608A4C4-EB5A-4C88-BD8C-40202FBF3DAAQ27003945-F21AB873-A119-48FD-B92B-AC76EE952E35Q28288148-55698450-A80C-4058-A5AB-958D198BDBDCQ33757096-3FB60D90-7CB0-4C1C-82C1-9AE4700E01B4Q33777494-B33AD6B8-F0E7-4049-9144-504A72338F47Q34075901-F5F54E83-84AC-432D-9CBA-AF2C61B82C65Q34190659-005BEC68-15A8-4AF9-AD82-DEE198467B71Q34987026-EBEB3C13-785A-4C98-A385-D1F2533B74D5Q34992889-18837BAB-78A5-48D6-8FDB-A4488A10D30FQ35635079-E3CEACF9-34B8-4113-B5CB-C662B2DE8F24Q35662257-B8143D23-6E0F-4F8E-9212-B04DC7ED80C2Q35760031-D29488DC-A0BF-462B-AD02-5B32A55D5810Q35892721-2549565D-1C8E-4B7F-B99B-6763548EAB05Q36201708-B830909C-5A2C-44C7-BB6B-7D392D6D35AFQ36269582-9F222CA7-8868-4D76-B2B0-6A668D5FC8E8Q36796256-A5BB7FB5-0A69-4E06-B82B-E82C0AE992DCQ36867284-B2DABE32-8EF4-42C1-A1A2-EBC8AABF38EEQ38127246-23500F12-1F1E-4C74-B779-924E5E219EDCQ38845891-D7E51D66-A305-45A1-88F5-5C3D0D400FC3Q39176356-35698599-88CC-49B9-9B0F-810E2F27473AQ39240976-E95FEEC9-CF70-4906-B210-54575BF73876Q42720277-4DEBA585-0BB5-47B1-A89D-91572BB95FD0Q47133700-6FBED1CD-310C-4D4E-8005-A6C169FBE130Q47748198-F67E6491-940A-4F47-BF2F-0D6E1B238DFFQ51088787-AA8829C6-F700-414B-B31B-36597057E0CBQ54972094-D35CDF7A-8A94-4F42-BD60-6D109F1FB4BDQ58308079-CF6B8530-B608-4EAF-85D3-460704D4B3D3Q59126848-8E898EB4-509E-4890-B8A9-E21E35F2A83D
P2860
Small-molecule anticancer compounds selectively target the hemopexin domain of matrix metalloproteinase-9
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Small-molecule anticancer comp ...... of matrix metalloproteinase-9
@ast
Small-molecule anticancer comp ...... of matrix metalloproteinase-9
@en
type
label
Small-molecule anticancer comp ...... of matrix metalloproteinase-9
@ast
Small-molecule anticancer comp ...... of matrix metalloproteinase-9
@en
prefLabel
Small-molecule anticancer comp ...... of matrix metalloproteinase-9
@ast
Small-molecule anticancer comp ...... of matrix metalloproteinase-9
@en
P2093
P2860
P1433
P1476
Small-molecule anticancer comp ...... of matrix metalloproteinase-9
@en
P2093
Antoine Dufour
Jennifer L Deleon
Nadia Jaber
Robert C Rizzo
Stanley Zucker
P2860
P304
P356
10.1158/0008-5472.CAN-10-4552
P407
P577
2011-06-06T00:00:00Z